The 2009 swine flu scare has had an unexpected benefit for the food allergy community. On March 1, the US Department of Health and Human Services announced contracts with two companies to manufacture flu vaccine. The 2009 swine flu pandemic proved that companies were unable to meet the demand for vaccine quickly enough using traditional egg-based methods of production.
Novavax and VaxInnate are the manufacturers of these next-generation recombinant influenza vaccines. Novavax is to develop new technology to produce vaccines using insect cells to express influenza proteins and create virus-like particles that stimulate a strong immune response in humans.VaxInnate is developing a recombinant influenza vaccine technology based on combining influenza and bacteria proteins to stimulate strong immune response to protect against the flu.
People will be able to get the vaccine earlier in the season and these new vaccines by-pass the guessing game of which strain of the virus should be in the vaccine.
I'll keep you posted on more information as it is released.
Finally, egg allergic kids and adults won't have to weight the risk of their allergy against the risk of getting the flu!